MedPath

SODIUM BICARBONATE USP FOR HEMODIALYSIS D12276

SODIUM BICARBONATE USP FOR HEMODIALYSIS D12276

Discontinued
DIN Number

02221616

Drug Class

Human

Market Date

Sep 10, 1996

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02221616
AIG Number0104153021
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormPowder
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM BICARBONATEActive
Strength: 650 G / SACHET
Monograph: SODIUM BICARBONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.